Search hospitals > Idaho > Nampa
Saint Luke's Cancer Institute - Nampa
Claim this profileNampa, Idaho 83686
Global Leader in Parotid Gland Cancer
Global Leader in Lung Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Breast Cancer
Conducts research for Relapse
248 reported clinical trials
6 medical researchers
Summary
Saint Luke's Cancer Institute - Nampa is a medical facility located in Nampa, Idaho. This center is recognized for care of Parotid Gland Cancer, Lung Cancer, Cervical Adenocarcinoma, Breast Cancer, Relapse and other specialties. Saint Luke's Cancer Institute - Nampa is involved with conducting 248 clinical trials across 451 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Alison K. ConlinProvidence Portland Medical Center6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Breast Cancer
107 reported clinical trials
183 drugs studied
Charles W. DrescherProvidence Portland Medical Center8 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cancer
53 reported clinical trials
99 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Parotid Gland Cancer
Studies Cervical Adenocarcinoma
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center5 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Cervical Adenocarcinoma
26 reported clinical trials
63 drugs studied
Clinical Trials running at Saint Luke's Cancer Institute - Nampa
Breast Cancer
Cancer
Parotid Gland Cancer
Lung Cancer
Pancreatic Cancer
Breast cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Bladder Cancer
Bladder Carcinoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Luke's Cancer Institute - Nampa?
Saint Luke's Cancer Institute - Nampa is a medical facility located in Nampa, Idaho. This center is recognized for care of Parotid Gland Cancer, Lung Cancer, Cervical Adenocarcinoma, Breast Cancer, Relapse and other specialties. Saint Luke's Cancer Institute - Nampa is involved with conducting 248 clinical trials across 451 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.